Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
Join this engaging and informative event entitled “Optimising Outcomes in Myeloma”, chaired by Dr Mamta Garg (University Hospitals of Leicester) and Dr Jennifer Travers (Beatson West of Scotland Cancer Centre). This in person and virtual conference brings together leading experts to discuss cutting-edge research, emerging therapies, and practical approaches to improving patient outcomes.
Event highlights
UK practice and trials updates: Stay informed on the latest developments in UK myeloma care.
Minimal Residual Disease (MRD) Testing: Explore transformative technologies like mass spectrometry, flow cytometry, and next-generation sequencing. Engage in a panel discussion on MRD’s role in UK practice.
IMS / ASH bursary insights: Discover exciting research presentations from emerging leaders, including advances in immunotherapy, NK cell biology, and novel therapeutic agents.
Who should attend
This conference is ideal for haematologists, oncologists, researchers, and healthcare professionals committed to improving outcomes for myeloma patients.
–
